Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BCLI

Stock Price & Analysis

-
stocks logo
BCLI
-
$
0.000
0.000(0%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

BCLI Stock Price Chart

5D
1M
3M
6M
YTD
1Y
5Y

BCLI Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

BCLI Company Profile

banner

BCLI Technical Analysis

Instant technical analysis with one click on any asset

banner

BCLI Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy BCLI

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

BCLI News Sentiment

AI uncovers potential trading opportunities based on news sentiment

banner

BCLI Technical Analysis

Instant technical analysis with one click on any asset

banner

BCLI Why It Moves

Find out the reasons behind the current stock movement

banner

Should I Buy BCLI

AI-powered analysis to guide your buy, sell, or hold decision for this stock

banner

BCLI News Sentiment

AI uncovers potential trading opportunities based on news sentiment

BCLI Fundamental Analysis

Moderate Buy
Buy
Hold
Sell
bubble
High
bubble
Averages
bubble
Low
Analyst
Rating
Action
Price Target
Date
Rating Reason

BCLI News

BCLI FAQs

What is surpport and resistant level for BCLI Stock?

The S1 support level for BCLI Stock is $1.77 ,The R1 resistant level for BCLI Stock is $2.2.

What is the current price of BCLI Stock?

As of the end of day on 2025-02-05, the price of BCLI Stock was $1.83.

What is the target price of BCLI Stock?

The target price for BCLI Stock according to analyst rating is 10.00, with the highest price target at 10.00 and the lowest at 10.00. Analysts have a Moderate Buy rating on BCLI Stock overall.

What is the market cap of Brainstorm Cell Therapeutics Inc?

The market cap of BCLI is $10.8M.

What is Brainstorm Cell Therapeutics Inc (BCLI)'s business?

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimers disease (AD) and other neurodegenerative diseases. NurOwn, the Company’s cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. NurOwn has completed its Phase III ALS and Phase II PMS clinical trials. Its wholly owned Israeli subsidiary, BrainStorm Cell Therapeutics Ltd., holds rights to commercialize its NurOwn technology. Its other subsidiaries include Advanced Cell Therapies Ltd. and two others.

How many employees does BCLI have?

BCLI has a total of 29 employees.

BCLI Key Stats

High
Vol
Low
Amount
Open
VWAP
Mkt Cap

BCLI Company Profile

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free